4.7 Article

Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands

Aline H. de Nooijer et al.

Summary: Obesity is recognized as a risk factor for adverse outcomes in COVID-19, but the molecular mechanisms underlying this relationship are still unclear. This study found that leptin and adiponectin are associated with BMI, but not with clinical outcomes and inflammation in COVID-19 patients. In contrast, resistin is not associated with BMI, but high concentrations are associated with worse clinical outcomes and more pronounced inflammation.

CLINICAL OBESITY (2023)

Article Cell Biology

Mechanisms contributing to adverse outcomes of COVID-19 in obesity

Manu Sudhakar et al.

Summary: Epidemiological data from multiple countries indicate an increased prevalence of obesity, especially central obesity, among hospitalized subjects with COVID-19. Obesity is a metabolic disorder that affects immune and endocrine function, and it is a major contributing factor to adverse outcomes in COVID-19.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)

Review Biochemistry & Molecular Biology

The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems

Monica Misch et al.

Summary: This review examines the role of leptin in weight control and metabolic homeostasis, as well as the detrimental effects of chronically high levels of leptin on various systems. The paper calls for further research on the receptor-mediated effects of leptin and leptin resistance, and provides an alternative perspective on the non-anorexic roles of leptin in health and disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Health Care Sciences & Services

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome

Carles Perpinan et al.

Summary: This study investigates the feasibility of using baseline cytokines as early prognostic biomarkers for COVID-19, and analyzes the impact of comorbidities such as obesity or metabolic syndrome on the cytokine profile. The results reveal that resistin and IL-15 are associated with worse prognosis of COVID-19 and serve as the best early predictors for requiring invasive ventilation.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Immunology

Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19

Takeshi Ebihara et al.

Summary: Resistin levels were elevated in COVID-19 patients and correlated with cytokines and endothelial cell adhesion molecules. Higher resistin levels were associated with worse outcome.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biology

Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients

Vito D'Agnano et al.

Summary: Serum KL-6 is significantly associated with the risk of death or intubation in severe to critical COVID-19 patients.

LIFE-BASEL (2022)

Article Infectious Diseases

Adipokines and the risk of active TB: a nested case-control study

A. Z. Soh et al.

Summary: Leptin and resistin levels were found to be inversely associated with the risk of active TB in this study, suggesting that higher serum levels of these adipokines may be protective against TB infection. Adiponectin and ghrelin levels, on the other hand, did not show significant associations with TB risk.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)

Article Cell Biology

Leptin correlates with monocytes activation and severe condition in COVID-19 patients

Jingya Wang et al.

Summary: Leptin, a cytokine found in significantly altered profiles in severe COVID-19 patients, correlates with disease severity and may exacerbate or dysregulate immune responses through activating monocytes. This study suggests a possible mechanism by which overweight COVID-19 patients have a greater tendency to develop severe conditions, providing insights into potential therapeutic strategies.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions

Ana Rita de Oliveira dos Santos et al.

Summary: Adipokines, myokines, and hepatokines are endocrine markers produced by adipose, skeletal, and hepatic muscle tissues, respectively, which can have harmful or beneficial effects on an organism. The interactions between these markers in the body can contribute to the development of various physiological disorders, such as type 2 diabetes, obesity, metabolic syndrome, and cardiovascular diseases. The understanding of these interactions may provide insights into potential therapeutic targets for diagnosing and treating metabolic syndrome and cardiovascular diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Surgery

2019 (COVID-19) and 2021

Paul B. S. Lai

SURGICAL PRACTICE (2021)

Article Oncology

Resistin: A journey from metabolism to cancer

Ankita Deb et al.

Summary: Resistin, a small secretory molecule, is implicated in insulin resistance development under obese conditions. It is associated with metabolic disorders, cardiovascular diseases, and cancers. Studies suggest it plays a pivotal role in cancer cell proliferation, metastasis, inflammation, and metabolism.

TRANSLATIONAL ONCOLOGY (2021)

Article Immunology

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time

Thomas L. Rodebaugh et al.

Summary: The progression of COVID-19 symptoms during the initial weeks is highly diverse, with significant variations among individuals. Some patients experience persistently severe symptoms or develop new symptoms days after diagnosis. Those who show clinical deterioration are more likely to have severe cough and diarrhea symptoms.

OPEN FORUM INFECTIOUS DISEASES (2021)

Review Biochemistry & Molecular Biology

The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness

Stephen J. Kuperberg et al.

Summary: The COVID-19 pandemic has significantly impacted the world, with obesity being closely linked to severe outcomes of the disease. Obesity can alter the immune system and increase the risk of inflammation.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Review Medicine, General & Internal

Obesity as an adipose tissue dysfunction disease and a risk factor for infections-Covid-19 as a case study

M. F. Landecho et al.

Summary: COVID-19 poses a significant threat to obese individuals, with mechanisms including the virus entering cells via the Angiotensin Converting Enzyme 2 receptor, inflammatory mediators in adipose tissue, and mechanical constraints in the thorax due to obesity. The prognosis for obese individuals with COVID-19 is negatively impacted.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?

Valeria Guglielmi et al.

Summary: Obesity is associated with increased severity of viral infections due to metabolic complications, nutritional aspects, lack of physical activity, and chronic hormonal and adipocytokine imbalance. High leptin concentrations in obesity impair immune surveillance and contribute to immune response dysregulation, potentially leading to reduced vaccine effectiveness. Overcoming leptin resistance and understanding its interactions with inflammation and the immune system remain major challenges for future research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Endocrinology & Metabolism

Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis

Klara Komici et al.

Summary: The study found that sarcopenia is linked to higher adiponectin levels, especially in Asian populations, with significant influence from female gender. However, caution is advised in interpreting these findings, and further longitudinal research is necessary for a better understanding of the topic.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Medicine, General & Internal

Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity

Andreea-Luciana Buicu et al.

Summary: COVID-19 is considered an inflammatory disease that can lead to a cytokine storm and multi-organ damage. Chronic inflammatory conditions like chronic coronary diseases, type 2 diabetes, and obesity play a significant role in the clinical outcomes of COVID-19 patients, with a potential for worsened prognosis.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Cell Biology

Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review

Fien Demeulemeester et al.

Summary: Obesity is a major risk factor for severe complications in COVID-19, potentially leading to increased disease severity through facilitating viral entry, chronic inflammation, and coagulation dysfunction.
Review Immunology

COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality

Radheshyam Maurya et al.

Summary: Obesity is a significant risk factor in coronavirus infection, particularly in leading to severe illness and increased mortality rates during the pandemic. Leptin, a hormone secreted by adipocytes in proportion to body fat mass, plays a crucial role in regulating appetite and immunity, with leptin deficiency or resistance linked to dysregulation of cytokine secretion and increased susceptibility to autoimmune disorders, inflammatory responses, and infectious diseases. The dysregulation of leptin activity in obese patients may contribute to high mortality rates during SARS-CoV-2 infection.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants

Filippo Scialo et al.

Summary: The COVID-19 pandemic has had a significant impact on socio-economic life, especially posing higher risks for individuals with underlying health conditions. Despite year-long efforts in academic research, there is still much to learn about SARS-CoV-2 and its potential future impacts on human health.

BIOMEDICINES (2021)

Review Endocrinology & Metabolism

COVID-19 and Obesity: Overlapping of Two Pandemics

Maria Alessandra Gammone et al.

Summary: This review examines the intersection between obesity and adverse outcomes of COVID-19, highlighting the close link between obesity and chronic systemic inflammation, as well as the challenges in diagnosis and care of obese patients with COVID-19. The aim is to investigate the preventive and therapeutic potential in the management of obesity-related COVID-19 complications.

OBESITY FACTS (2021)

Article Multidisciplinary Sciences

Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy

Andrea Bianco et al.

Summary: Comparing the early CT findings in patients with COVID-19 pneumonia and AH1N1 pneumonia, a higher prevalence of vascular enlargement was observed in COVID-19 patients. This vascular enlargement was predominantly located in bilateral, peripheral GGO or consolidation areas in the lower lobes. The vascular enlargement may serve as a relatively common early CT marker in COVID-19 patients, although the etiology remains uncertain.

HELIYON (2021)

Article Physiology

Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study

Sean M. Kearns et al.

Summary: A retrospective case-control study found significantly lower levels of adiponectin in patients with COVID-19 respiratory failure compared to other infectious respiratory failure patients, even after adjusting for covariates. Larger studies are needed to confirm these findings and further investigate the relationship between adiponectin levels and COVID-19 respiratory failure.

PHYSIOLOGICAL REPORTS (2021)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Biochemistry & Molecular Biology

Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study

Ersilia Nigro et al.

BIOMOLECULES (2020)

Editorial Material Endocrinology & Metabolism

COVID-19 Rise in Younger Adults with Obesity: Visceral Adiposity Can Predict the Risk

Gianluca Iacobellis et al.

OBESITY (2020)

Article Respiratory System

Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease

Fabio Perrotta et al.

COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)

Review Endocrinology & Metabolism

Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways

Ersilia Nigro et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)

Review Medicine, General & Internal

Adiponectin: Role in physiology and pathophysiology

Thi Diep Nguyen

INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2020)

Review Respiratory System

COVID-19 and coagulative axis: review of emerging aspects in a novel disease

Matilde Boccia et al.

MONALDI ARCHIVES FOR CHEST DISEASE (2020)

Article Respiratory System

Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function

Osric A. Forrest et al.

JOURNAL OF CYSTIC FIBROSIS (2019)

Article Pharmacology & Pharmacy

The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement

E. Nigro et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)

Review Pharmacology & Pharmacy

The burden of obesity in asthma and COPD: Role of adiponectin

Andrea Bianco et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Pharmacology & Pharmacy

Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome

Donato Lacedonia et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)

Review Cardiac & Cardiovascular Systems

Adipokines: A link between obesity and cardiovascular disease

Kazuto Nakamura et al.

JOURNAL OF CARDIOLOGY (2014)

Review Endocrinology & Metabolism

Assembly of adiponectin oligomers

Tsu-Shuen Tsao

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)

Review Biotechnology & Applied Microbiology

New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases

Ersilia Nigro et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Immunology

Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma

Sirpa Leivo-Korpela et al.

JOURNAL OF INFLAMMATION-LONDON (2011)